Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunomodulatory effects of dental pulp stem cells on lymphocytes and monocytes from patients with rheumatoid arthritis. | Clin Exp Rheumatol | 2025 | 40338061 | PubTator, text mining | PubMed |
| In Vitro Expansion and Transduction of Primary NK Cells Using Feeder Cells Expressing Costimulatory Molecules and IL-21. | Cancer Sci | 2025 | 40325497 | PubTator, text mining | PubMed |
| Identification and experimental verification of biomarkers related to butyrate metabolism in osteoarthritis. | Sci Rep | 2025 | 40195426 | PubTator, text mining | PubMed |
| Assessment of antigen immunogenicity formulated in minigenes transfected into antigen-presenting cells. | PLoS One | 2025 | 40193826 | PubTator, text mining | PubMed |
| Combining immune checkpoints with TNFSF agonists: a new horizon for cancer and autoimmune therapies. | Front Immunol | 2025 | 40165967 | PubTator, text mining | PubMed |
| Integrative analysis of bulk and single-cell sequencing reveals TNFSF9 as a potential regulator in microsatellite instability stomach adenocarcinoma. | Eur J Med Res | 2025 | 40148957 | PubTator, text mining | PubMed |
| Colorectal Organoids: Models, Imaging, Omics, Therapy, Immunology, and Ethics. | Cells | 2025 | 40136707 | PubTator, text mining | PubMed |
| Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis. | J Immunol | 2025 | 40127640 | PubTator, text mining | PubMed |
| Antigen-presenting fibroblasts: emerging players in immune modulation and therapeutic targets. | Theranostics | 2025 | 40093895 | PubTator, text mining | PubMed |
| MD Simulation Reveals a Trimerization-Enhanced Interaction of CD137L with CD137. | Int J Mol Sci | 2025 | 40076530 | PubTator, text mining | PubMed |
| Red blood cells-derived components as biomimetic functional materials: Matching versatile delivery strategies based on structure and function. | Bioact Mater | 2025 | 40034412 | PubTator, text mining | PubMed |
| The polyamine-regulating enzyme SSAT1 impairs tissue regulatory T cell function in chronic cutaneous inflammation. | Immunity | 2025 | 40023161 | PubTator, text mining | PubMed |
| Intratumoral gene delivery of 4-1BBL boosts IL-12-triggered anti-glioblastoma immunity. | bioRxiv | 2025 | 39975249 | PubTator, text mining | PubMed |
| Enhanced Natural Killer Cell Proliferation by Stress-Induced Feeder Cells. | Biotechnol Bioeng | 2025 | 39930883 | PubTator, text mining | PubMed |
| Engineered Immunomodulatory Extracellular Vesicles from Epithelial Cells with the Capacity for Stimulation of Innate and Adaptive Immunity in Cancer and Autoimmunity. | ACS Nano | 2025 | 39869047 | PubTator, text mining | PubMed |
| Plasma membrane-coated nanoparticles and membrane vesicles to orchestrate multimodal antitumor immunity. | J Immunother Cancer | 2025 | 39864848 | PubTator, text mining | PubMed |
| TNFSF9 Silence Impedes Cerebral Ischemia-Reperfusion Injury via Modulating SLC3A2 Expression in Brain Microvascular Endothelial Cells. | J Mol Neurosci | 2025 | 39856410 | PubTator, text mining | PubMed |
| Dual targeting PD-L1 and 4-1BB to overcome dendritic cell-mediated lenalidomide resistance in follicular lymphoma. | Signal Transduct Target Ther | 2025 | 39828715 | PubTator, text mining | PubMed |
| Shift work schedules alter immune cell regulation and accelerate cognitive impairment during aging. | J Neuroinflammation | 2025 | 39780172 | PubTator, text mining | PubMed |
| Causal relationship between inflammatory cytokines, metabolites, and ulcers of lower limb: A Mendelian randomization study. | Wound Repair Regen | 2025 | 39757880 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=7